Healthcare ETFs are exchange-traded funds that invest in pharma and healthcare companies, providing investors with convenient exposure to leading stocks in the sector. The table below compares various Healthcare and Pharma ETFs based on their assets under management (AUM), returns, and tracking errors.
Scheme Name | AUM (₹ Crore) | TER (%) | 1 Yr Rtn. (%) | 3 Yrs Rtn. (%) | Since Launch Rtn. (%) |
Motilal Oswal BSE Healthcare ETF | 32.76 | 0.23 | 1.71 | 24.36 | 23.2 |
ICICI Pru Nifty Healthcare ETF | 141.34 | 0.15 | 0.91 | 22.07 | 14.42 |
ABSL Nifty Healthcare ETF | 36.03 | 0.19 | 0.8 | 22.24 | 15.1 |
Axis NIFTY Healthcare ETF | 19.47 | 0.34 | 0.68 | 21.82 | 14.12 |
Nippon India Nifty Pharma ETF | 990.57 | 0.21 | -4.18 | 20.05 | 11.31 |
Source: Advisorkhoj
To explore more about each of these ETFs, you can visit Angel One's ETF page. This will give you a comprehensive overview of their latest NAVs, historical performance, and portfolio allocation.
Moreover, for a broader look at other mutual fund offerings and categories, you can go to Angel One’s mutual fund page.
Read More: Planning a ₹2 Crore Corpus Through SIP: Here’s How Much You Need to Invest.
In summary, Healthcare and Pharma ETFs offer a convenient way to gain exposure to leading companies in the sector, often with consistent medium- to long-term returns. Before investing, consider factors such as AUM, expense ratios, and past performance. For more detailed information and comparisons, visit Angel One’s ETF and mutual fund pages to make well-informed investment decisions.
Disclaimer: This blog has been written exclusively for educational purposes. The securities mentioned are only examples and not recommendations. This does not constitute a personal recommendation/investment advice. It does not aim to influence any individual or entity to make investment decisions. Recipients should conduct their own research and assessments to form an independent opinion about investment decisions.
Mutual Fund investments in the securities market are subject to market risks, read all the related documents carefully before investing.
Published on: Oct 14, 2025, 2:54 PM IST
We're Live on WhatsApp! Join our channel for market insights & updates